These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 990611)

  • 21. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity chromatography for subfractionation of 5-hydroxytryptamine-, LSD-binding proteins from cerebral and nerve-ending membranes.
    Mehl E; Weber L
    Adv Biochem Psychopharmacol; 1974; 11(0):105-8. PubMed ID: 4845693
    [No Abstract]   [Full Text] [Related]  

  • 23. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supra-ependymal serotoninergic nerves in mammalian brain: morphological, pharmacological and functional studies.
    Lorez HP; Richards JG
    Brain Res Bull; 1982; 9(1-6):727-41. PubMed ID: 6184136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.
    Quirion R; Richard J
    Synapse; 1987; 1(1):124-30. PubMed ID: 3145578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioautographic study of in vivo incorporation of 3H-monoamines in the cat caudate nucleus: identification of serotoninergic fibers.
    Calas A; Besson MJ; Gaughy C; Alonso G; Glowinski J; Cheramy A
    Brain Res; 1976 Dec; 118(1):1-13. PubMed ID: 990946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT release from ependymal surface of the caudate nucleus in 'encéphale isolé' cats.
    Ternaux JP; Hery F; Hamon M; Bourgoin S; Glowinski J
    Brain Res; 1977 Sep; 132(3):575-9. PubMed ID: 303139
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for an autoreceptor-mediated presynaptic control of serotonin release in central nerve endings [proceedings].
    Cerrito F; Raiteri M
    Br J Pharmacol; 1979 Nov; 67(3):424P-425P. PubMed ID: 497551
    [No Abstract]   [Full Text] [Related]  

  • 34. Binding of d-lysergic acid diethylamide to subcellular fractions from rat brain.
    Farrow JT; Van Vunakis H
    Nature; 1972 May; 237(5351):164-6. PubMed ID: 4555508
    [No Abstract]   [Full Text] [Related]  

  • 35. SEROTONIN BINDING TO NERVE-ENDING PARTICLES OF THE RAT BRAIN AND ITS INHIBITION BY LYSERGIC ACID DIETHYLAMIDE.
    MARCHBANKS RM; ROSENBLATT F; O'BRIEN RD
    Science; 1964 May; 144(3622):1135-6. PubMed ID: 14148433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioautographic study of 5-hydroxytryptamine-containing nerve terminals in central ganglia of Planorbis corneus: comparison with other species and characteristics of the serotoninergic nerve terminal.
    Pentreath VW; Berry MS
    J Neurocytol; 1978 Aug; 7(4):443-59. PubMed ID: 99497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin binding to nerve ending particles and other preparations from rat brain.
    Marchbanks RM
    J Neurochem; 1966 Dec; 13(12):1481-93. PubMed ID: 5962026
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Effects of inhibitors against the uptake of 45Ca at the neurosecretory nerve endings.
    Ishida A; Yoneda T
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):351-2. PubMed ID: 4478488
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of storage of transmitters in synaptic terminals.
    Smythies JR; Antun F; Yank G; Yorke C
    Nature; 1971 May; 231(5299):185-8. PubMed ID: 4930677
    [No Abstract]   [Full Text] [Related]  

  • 40. Uptake and metabolism of serotonin by ependymal primary cultures.
    Verleysdonk S; Hamprecht B; Rapp M; Wellard J
    Neurochem Res; 2004 Sep; 29(9):1739-47. PubMed ID: 15453270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.